1887

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) or human herpesvirus 8 is the causative agent of Kaposi's sarcoma, primary effusion lymphoma and the plasma-cell variant of multicentric Castleman's disease. Its alternatively spliced K15 gene encodes several membrane proteins with varying numbers of transmembrane domains. Two highly diverged alleles of the K15 gene, termed predominant (P) and minor (M), exist and share only 33 % amino acid identity with one another, but retain conserved putative src homology (SH) 2- and SH3-binding motifs. K15-M is thought to have entered the KSHV genome as the result of recombination with a related -herpesvirus. The more common K15-P allele has been shown to activate the mitogen-activated protein kinases Erk2 and JNK1 and the nuclear factor B (NF-B) pathway. To explore possible functional differences between K15-P and K15-M that might have influenced their spread in the KSHV population, here, the ability of the M form of K15 to activate these pathways was investigated. Similarly to K15-P, K15-M induces the activation of the Erk2 and JNK1 kinases, the NF-B transcription factor and the expression of a similar range of cellular inflammatory genes, as assessed by gene-expression microarray studies and reporter assays. In epithelial cells, the activation of most K15-M target genes is impaired by mutagenesis of Y in its SH2-binding motif YEEV, although this motif appears less important in endothelial cells. Therefore, K15-M and K15-P can trigger similar intracellular signalling pathways, despite their extensive sequence divergence.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.82807-0
2007-06-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/88/6/1698.html?itemId=/content/journal/jgv/10.1099/vir.0.82807-0&mimeType=html&fmt=ahah

References

  1. Alagiozoglou L., Sitas F., Morris L. 2000; Phylogenetic analysis of human herpesvirus-8 in South Africa and identification of a novel subgroup. J Gen Virol 81:2029–2038
    [Google Scholar]
  2. Biberfeld P., Ensoli B., Sturzl M., Schulz T. F. 1998; Kaposi sarcoma-associated herpesvirus/human herpesvirus 8, cytokines, growth factors and HIV in pathogenesis of Kaposi's sarcoma. Curr Opin Infect Dis 11:97–105 [CrossRef]
    [Google Scholar]
  3. Brinkmann M. M., Schulz T. F. 2006; Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae . J Gen Virol 87:1047–1074 [CrossRef]
    [Google Scholar]
  4. Brinkmann M. M., Glenn M., Rainbow L., Kieser A., Henke-Gendo C., Schulz T. F. 2003; Activation of mitogen-activated protein kinase and NF- κ B pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J Virol 77:9346–9358 [CrossRef]
    [Google Scholar]
  5. Brinkmann M. M., Pietrek M., Dittrich-Breiholz O., Kracht M., Schulz T. F. 2007; Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus. J Virol 81:42–58 [CrossRef]
    [Google Scholar]
  6. Cesarman E., Chang Y., Moore P. S., Said J. W., Knowles D. M. 1995; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191 [CrossRef]
    [Google Scholar]
  7. Chang Y., Cesarman E., Pessin M. S., Lee F., Culpepper J., Knowles D. M., Moore P. S. 1994; Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865–1869 [CrossRef]
    [Google Scholar]
  8. Choi J. K., Lee B. S., Shim S. N., Li M., Jung J. U. 2000; Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J Virol 74:436–446 [CrossRef]
    [Google Scholar]
  9. Dupin N., Marcelin A. G., Gorin I., Bossi P., Franck N., Weill B., Huraux J. M., Escande J. P., Calvez V. 1998; Prevalence of human herpesvirus 8 infection measured by antibodies to a latent nuclear antigen in patients with various dermatologic diseases. Arch Dermatol 134:700–702
    [Google Scholar]
  10. Geng Y., Eaton E. N., Picon M., Roberts J. M., Lundberg A. S., Gifford A., Sardet C., Weinberg R. A. 1996; Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12:1173–1180
    [Google Scholar]
  11. Glenn M., Rainbow L., Aurade F., Davison A., Schulz T. F. 1999; Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J Virol 73:6953–6963
    [Google Scholar]
  12. Hayward G. S., Zong J. C. 2007; Modern evolutionary history of the human KSHV genome. Curr Top Microbiol Immunol 312:1–42
    [Google Scholar]
  13. Hesser B. A., Liang X. H., Camenisch G., Yang S., Lewin D. A., Scheller R., Ferrara N., Gerber H. P. 2004; Down syndrome critical region protein 1 (DSCR1), a novel VEGF target gene that regulates expression of inflammatory markers on activated endothelial cells. Blood 104:149–158 [CrossRef]
    [Google Scholar]
  14. Jenner R. G., Alba M. M., Boshoff C., Kellam P. 2001; Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75:891–902 [CrossRef]
    [Google Scholar]
  15. Kakoola D. N., Sheldon J., Byabazaire N., Bowden R. J., Katongole-Mbidde E., Schulz T. F., Davison A. J. 2001; Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene. J Gen Virol 82:2393–2404
    [Google Scholar]
  16. Katano H., Sato Y., Kurata T., Mori S., Sata T. 2000; Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 269:335–344 [CrossRef]
    [Google Scholar]
  17. Lacoste V., Judde J. G., Briere J., Tulliez M., Garin B., Kassa-Kelembho E., Morvan J., Couppie P., Clyti E. other authors 2000; Molecular epidemiology of human herpesvirus 8 in Africa: both B and A5 K1 genotypes, as well as the M and P genotypes of K14.1/K15 loci, are frequent and widespread. Virology 278:60–74 [CrossRef]
    [Google Scholar]
  18. Meng Y. X., Sata T., Stamey F. R., Voevodin A., Katano H., Koizumi H., Deleon M., De Cristofano M. A., Galimberti R., Pellett P. E. 2001; Molecular characterization of strains of human herpesvirus 8 from Japan. Argentina and Kuwait. J Gen Virol 82:499–506
    [Google Scholar]
  19. Nakamura H., Lu M., Gwack Y., Souvlis J., Zeichner S. L., Jung J. U. 2003; Global changes in Kaposi's sarcoma-associated virus gene expression patterns following expression of a tetracycline-inducible Rta transactivator. J Virol 77:4205–4220 [CrossRef]
    [Google Scholar]
  20. Parravicini C., Chandran B., Corbellino M., Berti E., Paulli M., Moore P. S., Chang Y. 2000; Differential viral protein expression in Kaposi's sarcoma-associated herpesvirus-infected diseases: Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Am J Pathol 156:743–749 [CrossRef]
    [Google Scholar]
  21. Paulose-Murphy M., Ha N. K., Xiang C., Chen Y., Gillim L., Yarchoan R., Meltzer P., Bittner M., Trent J., Zeichner S. 2001; Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol 75:4843–4853 [CrossRef]
    [Google Scholar]
  22. Poole L. J., Zong J. C., Ciufo D. M., Alcendor D. J., Cannon J. S., Ambinder R., Orenstein J. M., Reitz M. S., Hayward G. S. 1999; Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol 73:6646–6660
    [Google Scholar]
  23. Rainbow L., Platt G. M., Simpson G. R., Sarid R., Gao S. J., Stoiber H., Herrington C. S., Moore P. S., Schulz T. F. 1997; The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71:5915–5921
    [Google Scholar]
  24. Russo J. J., Bohenzky R. A., Chien M. C., Chen J., Yan M., Maddalena D., Parry J. P., Peruzzi D., Edelman I. S. other authors 1996; Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862–14867 [CrossRef]
    [Google Scholar]
  25. Schulz T. F. 1999; Epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. Adv Cancer Res 76:121–160
    [Google Scholar]
  26. Schulz T. F. 2006; The pleiotropic effects of Kaposi's sarcoma herpesvirus. J Pathol 208:187–198 [CrossRef]
    [Google Scholar]
  27. Sharp T. V., Wang H.-W., Koumi A., Hollyman D., Endo Y., Ye H., Du M. Q., Boshoff C. 2002; K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol 76:802–816 [CrossRef]
    [Google Scholar]
  28. Soulier J., Grollet L., Oksenhendler E., Cacoub P., Cazals-Hatem D., Babinet P., d'Agay M. F., Clauvel J. P., Raphael M. other authors 1995; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86:1276–1280
    [Google Scholar]
  29. Sturzl M., Wunderlich A., Ascherl G., Hohenadl C., Monini P., Zietz C., Browning P. J., Neipel F., Biberfeld P., Ensoli B. 1999; Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study. Leukemia 13, (Suppl. 1):S110–S112
    [Google Scholar]
  30. Whitby D., Marshall V. A., Bagni R. K., Wang C. D., Gamache C. J., Guzman J. R., Kron M., Ebbesen P., Biggar R. J. 2004; Genotypic characterization of Kaposi's sarcoma-associated herpesvirus in asymptomatic infected subjects from isolated populations. J Gen Virol 85:155–163 [CrossRef]
    [Google Scholar]
  31. Zong J., Ciufo D. M., Viscidi R., Alagiozoglou L., Tyring S., Rady P., Orenstein J., Boto W., Kalumbuja H. other authors 2002; Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J Clin Virol 23:119–148 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.82807-0
Loading
/content/journal/jgv/10.1099/vir.0.82807-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error